Position in ABBV
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$42,091,822
+$8,278,653 QoQ
Shares Held
167,270
+7.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#412
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Livforsakringsbolaget Skandia, Omsesidigt holds $155,580,310 across 7 Drug Manufacturers - General names. ABBV ranks #3 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
222,206 | $56,433,657 | |
| 2 | LLY |
ELI LILLY & Co
|
43,930 | $52,690,963 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
167,270 | $42,091,822 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,394 | $2,106,629 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
8,417 | $1,063,403 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,732 | $906,477 | |
| 7 | BIIB |
Biogen Inc.
|
1,330 | $287,359 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,091,822 | 167,270 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $33,813,169 | 155,470 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $31,296,274 | 136,970 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $31,899,264 | 137,770 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $24,050,782 | 129,570 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $22,852,346 | 109,070 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $19,488,358 | 109,670 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $21,716,874 | 109,970 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $13,067,251 | 76,185 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $13,573,915 | 74,541 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $10,606,301 | 68,441 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $9,938,128 | 66,672 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $9,386,908 | 69,672 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $12,203,279 | 76,572 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,374,800 | 76,572 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,289,611 | 76,668 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,943,514 | 97,568 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $16,821,830 | 103,768 | Shares | Sole | 2022-06-21 | |
| 2021-12-31 | $12,438,927 | 91,868 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,524,659 | 97,568 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $11,485,675 | 101,968 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $10,255,792 | 94,768 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $7,652,438 | 71,418 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $5,335,806 | 60,918 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $6,157,652 | 62,718 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $3,714,033 | 48,747 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||